← Back to Clinical Trials
Recruiting NCT07802392

NCT07802392 Immersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07802392
Status Recruiting
Phase
Sponsor Consorci Sanitari de Terrassa
Condition Cognitive Dysfunction
Study Type INTERVENTIONAL
Enrollment 230 participants
Start Date 2026-03-31
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Immersive virtual reality program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 230 participants in total. It began in 2026-03-31 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate an immersive virtual reality program designed to support cognitive and emotional well-being in older adults with mild to moderate cognitive impairment. The program uses nature-based environments combined with mindfulness, cognitive stimulation, and breathing techniques. The goal is to determine whether immersive virtual reality can be a safe and effective tool to improve well-being and support active and healthy aging. The study will be conducted in two phases. In the first phase, virtual environments will be tested in healthy participants using behavioral and physiological measures. In the second phase, 200 older adults with cognitive impairment from day care centers and residential facilities will participate in a group-based immersive virtual reality intervention consisting of 10 sessions. Researchers will assess changes in cognitive function, emotional wellbeing, daily functioning, and quality of life before and after the intervention.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 65 years * Diagnosis of mild or moderate cognitive impairment * Ability to understand study procedures and follow instructions * Ability to provide informed consent (or consent provided by a legal representative) * Attendance at participating day care centers or residential facilities (Phase 2) * For Phase 1: healthy adults without cognitive impairment Exclusion Criteria: * Severe cognitive impairment or diagnosis of advanced dementia * Severe visual, auditory, or motor impairments that prevent use of virtual reality * Neurological or psychiatric conditions that may interfere with participation * History of epilepsy or conditions contraindicating virtual reality exposure * Severe behavioral disturbances or agitation * Participation in other clinical studies that may interfere with results

Contact & Investigator

Central Contact

Maite Garolera, PhD

✉ mgarolera@cst.cat

📞 +34937310007

Frequently Asked Questions

Who can join the NCT07802392 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07802392 currently recruiting?

Yes, NCT07802392 is actively recruiting participants. Contact the research team at mgarolera@cst.cat for enrollment information.

Where is the NCT07802392 trial being conducted?

This trial is being conducted at Terrassa, Spain.

Who is sponsoring the NCT07802392 clinical trial?

NCT07802392 is sponsored by Consorci Sanitari de Terrassa. The trial plans to enroll 230 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology